stem-cell and technology Resources | BNET
On TV.com: THE GIRLS NEXT DOOR photos

Resources

10 Resources for

stem-cell and technology

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, February 27th NXPC, PRXI, ADST, SCII, RCCH.
M2 PRESSWIRE-27 February 2008-OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, February 27th NXPC, PRXI, ADST, SCII, RCCHC1994-2008 M2 COMMUNICATIONS LTD RDATE:27022008 Our Stocks to Watch today include NeXplore Corporation (OTC: NXPC), Premier Exhibitions, Inc. (NASD: PRXI), AdStar, Inc....
Tags: advertisement, Company, exhibition, mobile, NASD, stem-cell, technology, Web
Research articles 2008-02-27
Octillion Shareholders to Receive Shares of MicroChannel Technologies on a One-for-One Basis on August 22
MicroChannel Technologies, a Wholly Owned Subsidiary, Will File Registration Statement with SEC to Effect Spin Out of MicroChannel Shares to Octillion Shareholders VANCOUVER, British Columbia -- In order to effect the spin out by Octillion Corp. of all of its shares of MicroChannel Technologies to Octillion shareholders of record...
Tags: Company, conduit, Dr., FINANCE, R&D, SEC, shareholder, stem-cell, substrate, technology, U.S.
Research articles 2007-08-08
Octillion to Focus on Solar Energy Technologies; Biotech Subsidiary to be Spun Out to Shareholders
MicroChannel Technologies, a Wholly Owned Subsidiary, Focused on Periphery and Optic Nerve Regeneration Technologies to Be Spun out to Octillion Shareholders of Record August 22, 2007; Octillion's Focus to Be on the Development of Solar Based Energy Technologies VANCOUVER, British Columbia -- As part of new initiatives to focus...
Tags: biotechnology, Company, conduit, Dr., SEC, shareholder, stem-cell, substrate, technology, U.S.
Research articles 2007-08-03
Healthcare News: HLUN & AFPC.
M2 PRESSWIRE-27 February 2007-StockProfiler.US: Healthcare News: HLUN & AFPCC1994-2007 M2 COMMUNICATIONS LTD RDATE:27022007 New York, NY - HEALTHeUNIVERSE Inc. (PINKSHEETS: HLUN); AFP Imaging Corporation (OTCBB: AFPC) Sign up Today for Your Free Stock and Updated News Subscription at ...
Tags: Agence France-Presse, Company, FINANCE, HARDWARE, imaging, patient, Scanners, SOFTWARE, stem-cell, surgery, technology
Research articles 2007-02-27
Techvest 7th Annual Healthcare Conference Presenter Profiles
NEW YORK -- Techvest 7th Annual Healthcare Conference takes place 07 - 09 Nov. at the New York Palace Hotel in New York City. For in-depth information about the event visit http://www.rodmanandrenshaw.com/index.htm. Below are profiles from Techvest 7th Annual Healthcare Conference presenters. News releases, web cast advisories, and photos...
Tags: Aksys Ltd., Amex, Antares Pharma Inc., ArQule Inc., biotechnology, cell, Chelsea, Company, compound, CytRx Corp., Discovery Laboratories Inc., EntreMed Inc., FDA, Inyx Inc., MARKETING, MicroIslet Inc., molecule, Nasdaq Stock Market Inc., OrthoLogic Corp., Oxigene Inc., patient, phone, Solexa Inc., stem-cell, StemCells Inc., technology, therapy, VioQuest Pharmaceuticals Inc., Web
Research articles 2005-11-04
Geron Wins Favorable Final Judgment in Third Nuclear Transfer Patent Interference
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) announced today that the Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office has issued a final judgment in interference number 105,192 between Geron and Advanced Cell Technology Corporation ("ACT") of Worcester, Mass. In its ruling, the Board found...
Tags: board, cell, embryo, Geron Corp., patent, stem-cell, technology, U.S. Patent and Trademark Office
Research articles 2005-02-24
SEBIO 2003 Exhibitor Profiles
Business/Biotechnology Writers SEBIO 2003 BIOWIRE2K PINEHURST, N.C.--BUSINESS WIRE--Nov. 10, 2003 SEBIO 2003 takes place Nov. 10-11 at the Pinehurst Resort, in Pinehurst, N.C. For in-depth information about the event visit http://www.sebio.org/2003/news/. Profiles from SEBIO 2003 exhibitors are listed below. Breaking news releases and advisories are...
Tags: Clarkston Consulting, Companies, Company, E-mail, HEALTHCARE, MEDIA, phone, stem-cell, Sutherland, technology
Research articles 2003-11-10
TR100/2002. (Mit's Magazine of Innovation: Technology Review).
All hail the TR100! These 100 brilliant young innovators--all under 35 as of Jan. 1, 2002--are visitors from the future, living among us here and now. Their innovations will have a deep impact on how we live, work and think in the century to come. A This is...
Tags: algorithm, battery, car, cell, chip, computer, Computer Associates International Inc., engineering, innovation, laser, Massachusetts Institute of Technology, network, patient, phone, polymer, professor, protein, researcher, software, stem-cell, technique, technology, Technology Review, tool, transistor, Web, wireless
Research articles 2002-06-01
Applied science; Local scientists- turned-entrepreneurs are experimenting with their own formula for success: corporate management experience, venture capital-and big ambitions.(Technology)
Byline: SARAH A. KLEIN Local scientists left jobless in a succession of technology and pharmaceutical industry mergers, spinoffs and acquisitions have turned into entrepreneurs to stay in Chicago and ply their trades. The Chicago Technology Park a Byline: SARAH A. KLEIN ...
Tags: company, Pfizer Inc., stem-cell, technology, venture capital
Research articles 2003-10-13
COMMISSION TO STAGE ROUND TABLE ON STEM CELLS.(European Commission)(Brief Article)
The European Group on ethics in science and technology is to stage a round table debate in Brussels on November 20 on ethical aspects of the patenting of innovations using human stem cells. The issues will be debated by scientific experts, lawyers, p The European Group...
Tags: commission, ethics, European Commission, stem-cell, technology
Research articles 2001-11-16

Additional Resources

Novocell CEO to Head Juvenile Diabetes Research Foundation
SAN DIEGO -- Novocell, Inc., a stem cell engineering company, today announced that President and Chief Executive Officer Alan J. Lewis, Ph.D., will leave the company effective January 1, 2009 to become the President and CEO of the Juvenile Diabetes Research Foundation. "Alan has contributed significantly to building...
Articles 2008-11-25
Research and Markets: Stem Cell Trendsetters in Neurology and Psychiatry Analyzed by NeuroInsights
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/84c9cc/stem_cell_appoache) has announced the addition of the "Stem Cell Approaches in Neurology and Psychiatry" report published by NeuroInsights to their offering. The industry insider report on innovative research and development in stem cell technology for the brain and nervous system provides unique insights into...
Articles 2008-11-24
You're not boarding with that - how transplant pioneers were
Private jet chartered after easyJet refused to carry stem cells THE TRANSPLANT of a lab-grown trachea was widely hailed as a major breakthrough in the science of stem- cell technology this week. But it almost never happened. Yesterday it emerged that the mad...
Articles 2008-11-21
Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
CAMBRIDGE, England, November 20 /PRNewswire-FirstCall/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, has signed a Master Service Agreement of up to five years with Pfizer Limited, the UK operating unit of the global research-based pharmaceutical company...
Articles 2008-11-20
Advanced Cell Technology Comments on Technology Platform
WORCESTER, Mass. -- Advanced Cell Technology, Inc. (OTC:ACTC) commented today on its technology platform. The Company noted that it believes it has the only technology that can produce stem cell lines of all types without the destruction of the embryo, which should increase the likelihood of receiving federal funding for...
Articles 2008-11-17
Celprogen Introduces an in vivo Model for Human Brain Cancer for Drug Discovery Applications
SAN PEDRO, Calif. -- Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for...
Articles 2008-11-17
HepaLife™ Patented 'PICM-19' Liver Stem Cell Line Launched Onboard Space Shuttle "Endeavour"
HepaLife's liver stem cell line launched onboard NASA's space shuttle mission STS-126 for special experiments during 15-day roundtrip to the International Space Station BOSTON -- HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), developing the first-of-its-kind bioartificial liver device intended for the treatment of liver failure, announced...
Articles 2008-11-17
Stem Cell Sciences Reinforces its International Patent Position in Stem Cell Technologies
CAMBRIDGE, England, November 14 /PRNewswire-FirstCall/ -- - European IRES Patent Upheld and UK Patent on Cell Screening Technology Granted - ("Stem Cell Sciences", "SCS", "the Company") IRES Patent Upheld in Appeal Hearing at the EPO Stem Cell Sciences plc (AIM:STEM, ASX:STC) announces that European...
Articles 2008-11-14
U.S. Cardiologist Reports Successful Treatment of Cardiovascular Disease Using Patients' Own Adult Stem Cells
Clinical Results of Adult Stem Cell Therapy Presented at International Regenerative Biomedical Technology Conference DUBAI, U.A.E. -- In a report unprecedented in the healthcare industry, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage cardiac...
Articles 2008-11-14
Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
CAMBRIDGE, England, November 11 /PRNewswire-FirstCall/ -- - ("Stem Cell Sciences", "SCS", "the Company") Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, announces that it has licensed IRES technology to a leading provider of genetically modified rat...
Articles 2008-11-11
  • << Previous
  • page 1 of 1
  • Next >>